LITS · Lite Strategy Inc
United States · RS rating 65 · As of 2026-10-14
| Price | 1.17 USD |
|---|---|
| 1-day change | -3.3% |
| RS rating (overall / 1M / 3M / 12M) | 65 / 92 / 91 / 16 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 22 / 23 / 9 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -583.3% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +48.2% |
| Market cap (USD) | $42.9M |